East Japan Railway (9020.T) traded down -1.12 % during a 24 hours period ending at 04:26 PM Central Europe on Monday 26th. One East Japan Railway stock can currently be bought for about JPY 3,736 on popular exchanges. Current supply of East Japan Railway stocks is 1.1 bn. East Japan Railway has a current market capitalization of JPY 4.1 trillions and approximately JPY 13.5 bn worth of East Japan Railway was traded on exchanges in the last 24 hours. Since last month end, East Japan Railway has traded 4.74 % up. Simple moving average of last 200 days is at JPY 3,617.98. The highest price of past 52 weeks was recorded at JPY 4,211 on 01/13/2026. 52 weeks low was at JPY 3,243 on 06/04/2026.

Summary of the latest news for East Japan Railway

East Japan Railway Company (JR East) has introduced two goats to graze on the grassed area outside Yotsuya Station in Tokyo’s Chiyoda Ward. The animals, a two‑year‑old female and a one‑year‑old male, were brought in as an environmentally friendly trial to control weeds. The experiment, launched in early October, was suggested by a station employee and has attracted public interest, with commuters and social‑media users sharing photos of the goats. JR East says the goats will continue grazing until the weeds are cleared, with no immediate plans to add more animals. The initiative has been described as a small but positive community engagement effort, adding a touch of nature to the busy station environment.

Here is how related stocks have performed in the past 24 hours:

  • Astellas Pharma (4503.T) traded up 0.98 % and now trades at JPY 2,558.5. Current market capitalisation for Astellas Pharma is JPY 4.5 trillions. Current price/earnings ratio for Astellas Pharma is 12.36. AstraZeneca’s experimental stomach‑cancer drug, an antibody‑drug conjugate called sone‑ve, has shown a significant improvement in patient survival in a late‑stage trial, according to a report presented at the European Society for Medical Oncology meeting. The study indicated that patients with advanced gastric cancer who received the treatment lived substantially longer than those on standard chemotherapy, particularly when the drug was used after two prior lines of therapy. While the therapy did not appear to delay disease progression, it was associated with a lower incidence of severe side effects compared with older treatments. AstraZeneca is in discussions with health authorities about the data and is exploring the drug’s potential as a new standard of care for advanced gastric cancer. The company’s broader research pipeline also includes a promising combination therapy for non‑small‑cell lung cancer that demonstrated extended survival and manageable safety in early trials.

  • Mitsubishi Estate (8802.T) traded up 2.76 % and now trades at JPY 3,939. Mitsubishi Estate has a market capitalisation of JPY 4.7 trillions. Mitsubishi Estate has a current price to earnings ratio of 16.37.

  • Sumitomo Mitsui (8309.T) traded down -1.45 % and now trades at JPY 1,606.5. Current market capitalisation for Sumitomo Mitsui is JPY 4.4 trillions. Sumitomo Mitsui has a current price to earnings ratio of 12.05.

  • Inpex (1605.T) traded down -1.46 % and now trades at JPY 4,049. Inpex has a market capitalisation of JPY 4.5 trillions. Inpex has a current price to earnings ratio of 10.54. In recent trading, the Nikkei 225 slipped modestly amid a broader slide in Asian equities, driven largely by weakness in technology shares. Energy stocks, however, posted gains as oil prices retreated from recent highs, supporting the performance of companies such as Inpex and JGC Holdings. The market reaction reflected concerns over higher interest rates and subdued domestic demand in China, coupled with ongoing geopolitical tensions in the Middle East that have kept commodity prices volatile. Despite the Nikkei’s short‑term technical pressure, analysts noted that energy names could offer a buffer as the broader index remains sensitive to global economic indicators and central bank policy outlooks.

  • Seven & I (3382.T) traded up 0.02 % and now trades at JPY 2,136.5. Seven & I has a market capitalisation of JPY 4.8 trillions. Current price/earnings ratio for Seven & I is 16.76.

About East Japan Railway

The East Japan Railway Co. is a leading industrial company providing rail transportation services in the Kanto and Tohoku regions, including Tokyo. The company’s offerings include the bullet train network and the Tokyo metropolitan network. Additionally, East Japan Railway leases real estate and operates hotels, travel, and restaurant businesses.